List of Tables
Table 1. Global Chronic Low Back Pain Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Chronic Low Back Pain Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Chronic Low Back Pain Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Chronic Low Back Pain Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Chronic Low Back Pain Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Chronic Low Back Pain Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Chronic Low Back Pain Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Chronic Low Back Pain Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Chronic Low Back Pain Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chronic Low Back Pain Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chronic Low Back Pain Drug, Product Type & Application
Table 12. Global Key Manufacturers of Chronic Low Back Pain Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chronic Low Back Pain Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Low Back Pain Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chronic Low Back Pain Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Chronic Low Back Pain Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Chronic Low Back Pain Drug Sales Market Share by Region (2020-2025)
Table 19. Global Chronic Low Back Pain Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Chronic Low Back Pain Drug Sales Market Share by Region (2026-2031)
Table 21. Global Chronic Low Back Pain Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Chronic Low Back Pain Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Chronic Low Back Pain Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Chronic Low Back Pain Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Chronic Low Back Pain Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Chronic Low Back Pain Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Chronic Low Back Pain Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Chronic Low Back Pain Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Chronic Low Back Pain Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Chronic Low Back Pain Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Chronic Low Back Pain Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Chronic Low Back Pain Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Chronic Low Back Pain Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Chronic Low Back Pain Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Chronic Low Back Pain Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Chronic Low Back Pain Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Chronic Low Back Pain Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Chronic Low Back Pain Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Chronic Low Back Pain Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Chronic Low Back Pain Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Chronic Low Back Pain Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Chronic Low Back Pain Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Chronic Low Back Pain Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Chronic Low Back Pain Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Chronic Low Back Pain Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Chronic Low Back Pain Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Chronic Low Back Pain Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Chronic Low Back Pain Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Chronic Low Back Pain Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Chronic Low Back Pain Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Chronic Low Back Pain Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Chronic Low Back Pain Drug Sales Market Share by Type (2020-2025)
Table 53. Global Chronic Low Back Pain Drug Sales Market Share by Type (2026-2031)
Table 54. Global Chronic Low Back Pain Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Chronic Low Back Pain Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Chronic Low Back Pain Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Chronic Low Back Pain Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Chronic Low Back Pain Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Chronic Low Back Pain Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Chronic Low Back Pain Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Chronic Low Back Pain Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Chronic Low Back Pain Drug Sales Market Share by Application (2020-2025)
Table 63. Global Chronic Low Back Pain Drug Sales Market Share by Application (2026-2031)
Table 64. Global Chronic Low Back Pain Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Chronic Low Back Pain Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Chronic Low Back Pain Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Chronic Low Back Pain Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Chronic Low Back Pain Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Chronic Low Back Pain Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Dr. Reddy's Laboratories Ltd Company Information
Table 71. Dr. Reddy's Laboratories Ltd Description and Business Overview
Table 72. Dr. Reddy's Laboratories Ltd Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Dr. Reddy's Laboratories Ltd Chronic Low Back Pain Drug Product
Table 74. Dr. Reddy's Laboratories Ltd Recent Developments/Updates
Table 75. Mylan Company Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Mylan Chronic Low Back Pain Drug Product
Table 79. Mylan Recent Developments/Updates
Table 80. Johnson & Johnson Company Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Johnson & Johnson Chronic Low Back Pain Drug Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Chronic Low Back Pain Drug Product
Table 89. Novartis Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sanofi Chronic Low Back Pain Drug Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Allergan Company Information
Table 96. Allergan Description and Business Overview
Table 97. Allergan Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Allergan Chronic Low Back Pain Drug Product
Table 99. Allergan Recent Developments/Updates
Table 100. Teva Pharmaceuticals Company Information
Table 101. Teva Pharmaceuticals Description and Business Overview
Table 102. Teva Pharmaceuticals Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Teva Pharmaceuticals Chronic Low Back Pain Drug Product
Table 104. Teva Pharmaceuticals Recent Developments/Updates
Table 105. Endo Pharmaceuticals Inc Company Information
Table 106. Endo Pharmaceuticals Inc Description and Business Overview
Table 107. Endo Pharmaceuticals Inc Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Endo Pharmaceuticals Inc Chronic Low Back Pain Drug Product
Table 109. Endo Pharmaceuticals Inc Recent Developments/Updates
Table 110. Eli Lilly and Company Company Information
Table 111. Eli Lilly and Company Description and Business Overview
Table 112. Eli Lilly and Company Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Eli Lilly and Company Chronic Low Back Pain Drug Product
Table 114. Eli Lilly and Company Recent Developments/Updates
Table 115. Pfizer Company Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Pfizer Chronic Low Back Pain Drug Product
Table 119. Pfizer Recent Developments/Updates
Table 120. Merck & Co., Inc. Company Information
Table 121. Merck & Co., Inc. Description and Business Overview
Table 122. Merck & Co., Inc. Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Merck & Co., Inc. Chronic Low Back Pain Drug Product
Table 124. Merck & Co., Inc. Recent Developments/Updates
Table 125. Takeda Pharmaceutical Company Information
Table 126. Takeda Pharmaceutical Description and Business Overview
Table 127. Takeda Pharmaceutical Chronic Low Back Pain Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Takeda Pharmaceutical Chronic Low Back Pain Drug Product
Table 129. Takeda Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Chronic Low Back Pain Drug Distributors List
Table 133. Chronic Low Back Pain Drug Customers List
Table 134. Chronic Low Back Pain Drug Market Trends
Table 135. Chronic Low Back Pain Drug Market Drivers
Table 136. Chronic Low Back Pain Drug Market Challenges
Table 137. Chronic Low Back Pain Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Chronic Low Back Pain Drug
Figure 2. Global Chronic Low Back Pain Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chronic Low Back Pain Drug Market Share by Type: 2024 & 2031
Figure 4. Analgesic medications Product Picture
Figure 5. Nonsteroidal anti-inflammatory drugs Product Picture
Figure 6. Counter irritants Product Picture
Figure 7. Antidepressants Product Picture
Figure 8. Anticonvulsants Product Picture
Figure 9. Global Chronic Low Back Pain Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Chronic Low Back Pain Drug Market Share by Application: 2024 & 2031
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Ambulatory Surgical Centers
Figure 14. Others
Figure 15. Global Chronic Low Back Pain Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Chronic Low Back Pain Drug Market Size (2020-2031) & (US$ Million)
Figure 17. Global Chronic Low Back Pain Drug Sales (2020-2031) & (K Units)
Figure 18. Global Chronic Low Back Pain Drug Average Price (US$/Unit) & (2020-2031)
Figure 19. Chronic Low Back Pain Drug Report Years Considered
Figure 20. Chronic Low Back Pain Drug Sales Share by Manufacturers in 2024
Figure 21. Global Chronic Low Back Pain Drug Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Chronic Low Back Pain Drug Players: Market Share by Revenue in Chronic Low Back Pain Drug in 2024
Figure 23. Chronic Low Back Pain Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Chronic Low Back Pain Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Chronic Low Back Pain Drug Sales Market Share by Country (2020-2031)
Figure 26. North America Chronic Low Back Pain Drug Revenue Market Share by Country (2020-2031)
Figure 27. United States Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Chronic Low Back Pain Drug Sales Market Share by Country (2020-2031)
Figure 30. Europe Chronic Low Back Pain Drug Revenue Market Share by Country (2020-2031)
Figure 31. Germany Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Chronic Low Back Pain Drug Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Chronic Low Back Pain Drug Revenue Market Share by Region (2020-2031)
Figure 38. China Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Chronic Low Back Pain Drug Sales Market Share by Country (2020-2031)
Figure 46. Latin America Chronic Low Back Pain Drug Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Chronic Low Back Pain Drug Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Chronic Low Back Pain Drug Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Chronic Low Back Pain Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Chronic Low Back Pain Drug by Type (2020-2031)
Figure 56. Global Revenue Market Share of Chronic Low Back Pain Drug by Type (2020-2031)
Figure 57. Global Chronic Low Back Pain Drug Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Chronic Low Back Pain Drug by Application (2020-2031)
Figure 59. Global Revenue Market Share of Chronic Low Back Pain Drug by Application (2020-2031)
Figure 60. Global Chronic Low Back Pain Drug Price (US$/Unit) by Application (2020-2031)
Figure 61. Chronic Low Back Pain Drug Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
